0.00
+0(+0.00%)
Currency In USD
| Previous Close | 0 |
| Open | 0 |
| Day High | 0 |
| Day Low | 0 |
| 52-Week High | 4.12 |
| 52-Week Low | 0 |
| Volume | 3,000 |
| Average Volume | 11.39M |
| Market Cap | 1,975 |
| PE | 0 |
| EPS | -3.05 |
| Moving Average 50 Days | 0.16 |
| Moving Average 200 Days | 0.93 |
| Change | 0 |
If you invested $1000 in Molecular Templates, Inc. (MTEM) 10 years ago, it would be worth $0 as of February 05, 2025 at a share price of $0. Whereas If you bought $1000 worth of Molecular Templates, Inc. (MTEM) shares 5 years ago, it would be worth $0 as of February 05, 2025 at a share price of $0.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules
GlobeNewswire Inc.
Dec 19, 2024 9:10 PM GMT
AUSTIN, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targete
Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements
GlobeNewswire Inc.
Dec 02, 2024 10:06 PM GMT
AUSTIN, Texas, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targete
Data not available